Form 4 for BSX Boston Scientific
Accepted 2024-02-08 00:00:00 ET · period of report 2024-02-06 · accession 0001225208-24-001780 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-08 | 2024-02-06 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | A - Grant | $0.00 | +146.7K | 1.70M | +9% | $0 | |
| 2024-02-08 | 2024-02-06 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $0.00 | -65.0K | 1.64M | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-06 | A | A | 146,666 | $0.00 | 1,701,403 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-06 | F | D | 65,047 | $0.00 | 1,636,356 | D | — | — |